Novo Nordisk’s Wegovy made a significant impact on the obesity market when it launched in 2021.
Tirzepatide outpacing Wegovy in the obesity space
January 2, 2025
You may also like
Indices by TradingView
Why Critical Metals Stock Is Plummeting Today
February 12, 2026
Amazon Pharmacy to expand same-day delivery to 4,500 cities in 2026
February 12, 2026
SoftBank books $4.2 billion gain on OpenAI bet, boosting its Vision Fund
February 12, 2026
Categories
Indices by TradingView




